Xvivo Perfusion (Sweden) Buy Hold or Sell Recommendation
| XVIVO Stock | SEK 321.00 7.00 2.13% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Xvivo Perfusion AB is 'Strong Sell'. Macroaxis provides Xvivo Perfusion buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding XVIVO positions. The advice algorithm takes into account all of Xvivo Perfusion's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Xvivo Perfusion's buy or sell advice are summarized below:
Real Value 258.4 | Hype Value 321 | Market Value 321 | Naive Value 347.99 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Xvivo Perfusion AB given historical horizon and risk tolerance towards Xvivo Perfusion. When Macroaxis issues a 'buy' or 'sell' recommendation for Xvivo Perfusion AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Xvivo |
Execute Xvivo Perfusion Buy or Sell Advice
The Xvivo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Xvivo Perfusion AB. Macroaxis does not own or have any residual interests in Xvivo Perfusion AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Xvivo Perfusion's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Xvivo Perfusion Trading Alerts and Improvement Suggestions
| Xvivo Perfusion AB had very high historical volatility over the last 90 days | |
| Xvivo Perfusion AB has accumulated about 398.7 M in cash with (12.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.45. | |
| Roughly 12.0% of the company outstanding shares are owned by insiders |
Xvivo Perfusion Returns Distribution Density
The distribution of Xvivo Perfusion's historical returns is an attempt to chart the uncertainty of Xvivo Perfusion's future price movements. The chart of the probability distribution of Xvivo Perfusion daily returns describes the distribution of returns around its average expected value. We use Xvivo Perfusion AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Xvivo Perfusion returns is essential to provide solid investment advice for Xvivo Perfusion.
| Mean Return | 0.01 | Value At Risk | -3.85 | Potential Upside | 3.89 | Standard Deviation | 3.03 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Xvivo Perfusion historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Xvivo Perfusion Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Xvivo Perfusion or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Xvivo Perfusion's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Xvivo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.05 | |
β | Beta against NYSE Composite | -0.83 | |
σ | Overall volatility | 3.03 | |
Ir | Information ratio | -0.02 |
Xvivo Perfusion Volatility Alert
Xvivo Perfusion AB shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Xvivo Perfusion's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Xvivo Perfusion's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Xvivo Perfusion Fundamentals Vs Peers
Comparing Xvivo Perfusion's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Xvivo Perfusion's direct or indirect competition across all of the common fundamentals between Xvivo Perfusion and the related equities. This way, we can detect undervalued stocks with similar characteristics as Xvivo Perfusion or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Xvivo Perfusion's fundamental indicators could also be used in its relative valuation, which is a method of valuing Xvivo Perfusion by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Xvivo Perfusion to competition |
| Fundamentals | Xvivo Perfusion | Peer Average |
| Return On Equity | 0.0136 | -0.31 |
| Return On Asset | 0.0057 | -0.14 |
| Profit Margin | 0.04 % | (1.27) % |
| Operating Margin | 0.04 % | (5.51) % |
| Current Valuation | 5.54 B | 16.62 B |
| Shares Outstanding | 29.83 M | 571.82 M |
| Shares Owned By Insiders | 12.25 % | 10.09 % |
| Shares Owned By Institutions | 54.00 % | 39.21 % |
| Price To Earning | 662.55 X | 28.72 X |
| Price To Book | 4.23 X | 9.51 X |
| Price To Sales | 16.58 X | 11.42 X |
| Revenue | 258.39 M | 9.43 B |
| Gross Profit | 296.96 M | 27.38 B |
| EBITDA | 39.2 M | 3.9 B |
| Net Income | 8.15 M | 570.98 M |
| Cash And Equivalents | 398.7 M | 2.7 B |
| Cash Per Share | 7.45 X | 5.01 X |
| Total Debt | 1.52 M | 5.32 B |
| Debt To Equity | 1.20 % | 48.70 % |
| Current Ratio | 4.69 X | 2.16 X |
| Book Value Per Share | 47.94 X | 1.93 K |
| Cash Flow From Operations | (12.06 M) | 971.22 M |
| Earnings Per Share | 0.99 X | 3.12 X |
| Target Price | 383.33 | |
| Number Of Employees | 133 | 18.84 K |
| Beta | 1.97 | -0.15 |
| Market Capitalization | 7.48 B | 19.03 B |
| Total Asset | 1.54 B | 29.47 B |
| Retained Earnings | 22 M | 9.33 B |
| Working Capital | 81 M | 1.48 B |
| Current Asset | 98 M | 9.34 B |
| Current Liabilities | 17 M | 7.9 B |
| Net Asset | 1.54 B |
Xvivo Perfusion Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Xvivo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0306 | |||
| Daily Balance Of Power | (0.70) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 322.0 | |||
| Day Typical Price | 321.67 | |||
| Market Facilitation Index | 10.0 | |||
| Price Action Indicator | (4.50) | |||
| Period Momentum Indicator | (7.00) |
About Xvivo Perfusion Buy or Sell Advice
When is the right time to buy or sell Xvivo Perfusion AB? Buying financial instruments such as Xvivo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Xvivo Perfusion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Xvivo Perfusion Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Xvivo Stock analysis
When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |